D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
RDHL holding history
RedHill Biopharma Ltd. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RDHL overviewAll 13F holders of RDHLFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −263−100.0% | Sold outConverted for a 1-for-40 split | Holders |
| Q4 2022 | 10,500 | $1.47K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 10,500 | $5.00K | <0.1% | −4,000−27.6% | Reduced | Holders |
| Q2 2022 | 14,500 | $13.0K | <0.1% | −2,300−13.7% | Reduced | Holders |
| Q1 2022 | 16,800 | $42.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 16,800 | $43.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 16,800 | $77.0K | <0.1% | −13,000−43.6% | Reduced | Holders |
| Q2 2021 | 29,800 | $205.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 29,800 | $218.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.